BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koch CA, Petersenn S. Neuroendocrine neoplasms – think about it and choose the most appropriate diagnostic and therapeutic steps. Rev Endocr Metab Disord 2018;19:107-9. [DOI: 10.1007/s11154-018-9472-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gubbi S, Koch CA, Klubo-Gwiezdzinska J. Peptide Receptor Radionuclide Therapy in Thyroid Cancer. Front Endocrinol (Lausanne) 2022;13:896287. [PMID: 35712243 DOI: 10.3389/fendo.2022.896287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Butler OL, Mekhael MM, Ahmed A, Cuthbertson DJ, Pritchard DM. Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center. Front Endocrinol (Lausanne) 2020;11:606264. [PMID: 33391185 DOI: 10.3389/fendo.2020.606264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Boons G, Vandamme T, Peeters M, Van Camp G, Op de Beeck K. Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies. Rev Endocr Metab Disord 2019;20:333-51. [DOI: 10.1007/s11154-019-09508-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Chuang T, Chang Y, Cheng W, Chiu Y, Chiu AW. WITHDRAWN: Double primary carcinoid tumors of the kidney. Asian Journal of Urology 2019. [DOI: 10.1016/j.ajur.2019.06.003] [Reference Citation Analysis]